Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
View/ Open
Author
Liu, Xinyang
Qin, Shukui
Wang, Zhichao
Xu, Jianming
Xiong, Jianping
Bai, Yuxian
Wang, Zhehai
Yang, Yan
Sun, Guoping
Wang, Liwei
Zheng, Leizhen
Xu, Nong
Cheng, Ying
Guo, Weijian
Yu, Hao
Liu, Tianshu
Li, Jin
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/s13045-017-0545-5Metadata
Show full item recordCitation
Liu, X., S. Qin, Z. Wang, J. Xu, J. Xiong, Y. Bai, Z. Wang, et al. 2018. “Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study.” Journal of Hematology & Oncology 11 (1): 5. doi:10.1186/s13045-017-0545-5. http://dx.doi.org/10.1186/s13045-017-0545-5.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759211/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:34869029
Collections
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)